About this trial
This study investigated the effect of mild gain amplification (8dB covering 1 Hz to 8kHz) as tinnitus treatment for participants with normal hearing and compared these effects with an active placebo condition using hearing aids without amplification in a double-blinded crossover study. 12 participants with normal hearing and chronic tinnitus were included in the study. Two different hearing aid treatments were provided for 3 weeks each: mild gain amplification that provided 8dB gain in the frequency range from 1 Hz to 8 kHz and no amplification, acting as placebo. The effect of the two treatments on tinnitus distress was evaluated with the Tinnitus Functional Index (TFI) questionnaire. The effect of the treatment on tinnitus loudness and annoyance were evaluated with a visual analog scale (VAS).
Eligibility criteria
Qualifiers
Daily bothersome tinnitus for at least 3 months (TFI>15)
Normal hearing (25 dB HL from 125 Hz to 8 kHz)
Inexperienced hearing aid user
Disqualifiers
Meniere's disease, Tosclerosis, Stapedectomy, Stapedotomy and Tympanoplasty
Objective or pulsatile tinnitus
Hearing thresholds >25 dB from 125 Hz to 8 kHz
Trial design
Treatments tested in this trial
- Hearing Aid with NR_4